Innovations in Medicinal Chemistry for Cancer Treatment
Keywords:
Medicinal chemistry, Cancer treatment, Nanomedicine, Nanotechnology, Tumor, Artificial intelligence (AI)Abstract
Millions of people die each year from cancer, an aberrant condition of cells that produces aggressive tumours and unchecked cell multiplication. The development of several novel treatment regimens and their subsequent trials are a result of our growing understanding of the illness and its molecular mechanism of progression. Many malignancies are very difficult to diagnose and identify early. High death rates are always the result of late-stage cancer discovery. The development of new, more sensitive, and more efficient diagnostic and therapeutic techniques for cancer therapy is essential. Review the many studies on advances in medicinal chemistry for the treatment of cancer in this article. The study found that by improving medication biodistribution, allowing precision medicine, and reducing adverse effects, "nanomedicine, targeted therapy, and nanotechnology" have transformed the treatment of cancer. Advances in gene therapy, immunotherapy, and AI-driven diagnostics further refine patient-specific treatments. Minimally invasive surgical techniques and thermal ablation offer effective alternatives to tumor resection. The integration of AI, nanorobots, and engineered nanomaterials enhances early detection, targeted drug delivery, and treatment efficacy. Collaborative efforts in medicinal chemistry and AI will continue to drive breakthroughs in cancer therapeutics, improving patient outcomes.
References
[1] R. Benedetti, M. Conte, C. Dell'Aversana, F. K. Hansen, and C. Zwergel, "Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research," Front. Chem., vol. 8, no. September, pp. 3-4, 2020,https://doi.org/10.3389/fchem.2020.00820
[2] M. Huang, J. J. Lu, and J. Ding, "Natural Products in Cancer Therapy: Past, Present and Future," Nat. Products Bioprospect., vol. 11, no. 1, pp. 5-13, 2021,https://doi.org/10.1007/s13659-020-00293-7
[3] P. Chunarkar-Patil et al., "Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies," Biomedicines, vol. 12, no. 1, pp. 1-35, 2024,https://doi.org/10.3390/biomedicines12010201
[4] P. Sharma, V. Jhawat, P. Mathur, and R. Dutt, "Innovation in cancer therapeutics and regulatory perspectives," Med. Oncol., vol. 39, no. 5, pp. 1-12, 2022,https://doi.org/10.1007/s12032-022-01677-0
[5] N. Chintapally et al., "State of cancer care in India and opportunities for innovation," Futur. Oncol., vol. 19, no. 39, pp. 2593-2606, 2023,https://doi.org/10.2217/fon-2023-0047
[6] T. Andreani et al., Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges, vol. 14, no. 10. Springer US, 2024.https://doi.org/10.1007/s13346-024-01649-z
[7] L. Sapio and S. Naviglio, "Innovation through Tradition: The Current Challenges in Cancer Treatment," Int. J. Mol. Sci., vol. 23, no. 10, pp. 10-12, 2022,https://doi.org/10.3390/ijms23105296
[8] M. Shams, S. Abdallah, L. Alsadoun, Y. H. Hamid, R. Gasim, and A. Hassan, "Oncological Horizons: The Synergy of Medical and Surgical Innovations in Cancer Treatment," Cureus, vol. 15, no. 11, 2023,https://doi.org/10.7759/cureus.49249
[9] S. P. Singh, S. K. Shukla, and R. Yadav, "Artificial intelligence and Machine learning- based approaches for Neurodegenerative Diseases Diagnosis," pp. 31-37, 2023.
[10] S. Chandra et al., "Scientific evidences of anticancer potential of medicinal plants," Food Chem. Adv., vol. 2, no. March, p. 100239, 2023,https://doi.org/10.1016/j.focha.2023.100239
[11] V. C. Deivayanai et al., "A comprehensive review on advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectives," Cancer Pathog. Ther., no. November, 2024,https://doi.org/10.1016/j.cpt.2024.11.002
[12] P. Dixit and P. B. Singh, "The Impact of Artificial Intelligence on Various Sectors: Benefits, Challenges, and Future Prospects," Interantional J. Sci. Res. Eng. Manag., vol. 08, no. 04, pp. 1-5, 2024,https://doi.org/10.55041/IJSREM30655
[13] G. Andreozzi et al., "Arylpiperazine Derivatives and Cancer: A New Challenge in Medicinal Chemistry," Pharmaceuticals, vol. 17, no. 10, 2024,https://doi.org/10.3390/ph17101320
[14] U. Anand et al., "Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics," Genes Dis., vol. 10, no. 4, pp. 1367-1401, 2023,https://doi.org/10.1016/j.gendis.2022.02.007
[15] T. J. Struble et al., "Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis," J. Med. Chem., vol. 63, no. 16, pp. 8667-8682, 2020,https://doi.org/10.1021/acs.jmedchem.9b02120
[16] J. Kuzminska et al., "Curcumin Derivatives in Medicinal Chemistry: Potential Applications in Cancer Treatment," Molecules, vol. 29, no. 22, 2024,https://doi.org/10.3390/molecules29225321
[17] B. Liu, H. Zhou, L. Tan, K. T. H. Siu, and X. Y. Guan, "Exploring treatment options in cancer: Tumor treatment strategies," Signal Transduct. Target. Ther., vol. 9, no. 1, 2024,https://doi.org/10.1038/s41392-024-01856-7
[18] X. Kong, P. Gao, J. Wang, Y. Fang, and K. C. Hwang, "Advances of medical nanorobots for future cancer treatments," J. Hematol. Oncol., vol. 16, no. 1, pp. 1-45, 2023,https://doi.org/10.1186/s13045-023-01463-z
[19] L. Helms, A. E. Guimera, K. A. Janeway, and K. M. Bailey, "Innovations in Cancer Treatment of Children," Pediatrics, vol. 152, no. 6, 2023,https://doi.org/10.1542/peds.2023-061539
[20] M. Chehelgerdi et al., "Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation," Mol. Cancer, vol. 22, no. 1, 2023,https://doi.org/10.1186/s12943-023-01865-0
[21] U. Anand et al., "Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics," Genes Dis., vol. 10, no. 4, pp. 1367-1401, 2022,https://doi.org/10.1016/j.gendis.2022.02.007
[22] C. Pucci, C. Martinelli, and G. Ciofani, "Innovative approaches for cancer treatment: Current perspectives and new challenges," Ecancermedicalscience, vol. 13, pp. 1-26, 2019,https://doi.org/10.3332/ecancer.2019.961
